We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks to Renew Rule for Environmental Assessments
FDA Seeks to Renew Rule for Environmental Assessments
February 2, 2010
Drugmakers will have to continue to include an environmental assessment (EA) of their manufacturing operations in drug applications or apply to waive the review if the Office of Management and Budget (OMB) approves the FDA’s request to renew the industry reporting requirement.